Loading...
Zydus Lifesciences Limited — Zinc Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #5 for Zinc · $1.5M export value · DGFT Verified
Zydus Lifesciences Limited is the #5 Indian exporter of Zinc with $1.5M in export value and 30 verified shipments. Zydus Lifesciences Limited holds a 1.9% market share in Zinc exports across 6 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $500.0K | 10 | 52.3% |
| SRI LANKA | $350.0K | 7 | 36.6% |
| MYANMAR | $40.2K | 5 | 4.2% |
| AFGHANISTAN | $27.2K | 2 | 2.8% |
| PHILIPPINES | $19.6K | 4 | 2.1% |
| PAKISTAN | $19.3K | 2 | 2.0% |
Zydus Lifesciences Limited exports Zinc to 6 countries. The largest destination is UNITED STATES accounting for 52.3% of Zydus Lifesciences Limited's Zinc shipments, followed by SRI LANKA (36.6%) and MYANMAR (4.2%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $500.0K | 10 |
| HEMAS PHARMACEUTICALS (PVT) LTD | SRI LANKA | $150.0K | 3 |
| HEMAS PHARMACEUTICAL (PVT) LTD. | SRI LANKA | $150.0K | 3 |
| HEMAS PHARMACEUTICALS (PRIVATE) LIMITED | SRI LANKA | $50.0K | 1 |
| RAOUFI GLOBAL GROUP COMPANY | PAKISTAN | $46.5K | 4 |
| AA MEDICAL PRODUCTS LTD | MYANMAR |
India exported $35.0M worth of Zinc through 7,960 shipments from 791 suppliers to 180 countries, serving 2,264 buyers globally. Zydus Lifesciences Limited contributes $1.5M to this total, accounting for 1.9% of India's Zinc exports. Zydus Lifesciences Limited ships Zinc to 6 countries through 9 buyers.
Zydus Lifesciences Limited's average Zinc shipment value is $50.0K per consignment, based on 30 shipments totaling $1.5M. The largest destination is UNITED STATES (52.3% of Zydus Lifesciences Limited's Zinc exports).
Zydus Lifesciences Limited ranks #5 among 791 Indian Zinc exporters with a 1.9% market share. The top 3 exporters are APEX LABORATORIES PRIVATE LIMITED ($12.2M), GOPALDAS VISRAM AND COMPANY LIMITED ($3.9M), INDUS LIFE SCIENCES PRIVATE LIMITED ($3.8M). Zydus Lifesciences Limited processed 30 shipments to 6 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ZINC SULFATE INJECTION USP 10 MG/10ML 1MG/ML [1X25 VIAL PER PACK]VLS | $150.0K | 3 |
| ZINC SULFATE INJECTION USP 25 MG/5 ML 5MG/ML - 1 X 25'S VIAL (5022X1X25)VLS | $150.0K | 3 |
| FERUP SG 4X30 CAPSULES (FERROUS FUMARATEB.P. 152MG,FOLIC ACID 400MCG, ZINCE SULPHATE BP 15MG & VITAMIN B12BP.0015MG) 4X | $150.0K | 3 |
| FERUP SG 4X30 CAPSULES,(FERROUS FUMARATEB.P. 152MG,FOLIC ACID 400MCG, ZINCE SULPHATE BP 15MG & VITAMIN B12BP.0015MG) | $100.0K | 2 |
| ZINC SULFATE INJECTION USP 30MG/10ML 3MG/ML [1X25 VIAL PER PACK]VLS | $50.0K | 1 |
| PHARMA MEDICINE FOR HUMAN USE-ZINC SULFATE INJECTION USP 30 MG/10 ML 3 MG/ML - 1X 25'S VIAL-QTY.672.000 PAC-AS PER INVO | $50.0K | 1 |
| FERUP SG 4X30 CAPSULES(FERROUS FUMARATEB.P. 152MGFOLIC ACID 400MCG ZINCE SULPHATE BP 15MG & VITAMIN B12BP.0015MG)NOS | $50.0K | 1 |
What Zydus Lifesciences Limited must comply with to export Zinc to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | DR REDDYS LABORATORIES LIMITED | $2.0M | 40 | 5 | $50.0K |
| 9 | MEPRO PHARMACEUTICALS PRIVATE LIMITED | $1.6M | 73 | 11 | $21.9K |
| 5 | ZYDUS LIFESCIENCES LIMITED ★ | $1.5M | 30 | 6 | $50.0K |
| 10 | UMENDRA EXPORTS PRIVATE LIMITED | $1.3M | 101 | 1 |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 839 | 10.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 814 | 10.2% |
| SAHAR AIR | 758 | 9.5% |
| DELHI AIR | 501 | 6.3% |
| JNPT/ NHAVA SHEVA SEA | 462 | 5.8% |
| DELHI AIR CARGO ACC (INDEL4) | 446 | 5.6% |
| JNPT | 383 | 4.8% |
| CHENNAI SEA | 252 | 3.2% |
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Zinc, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Zinc — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Zinc exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
| $30.8K |
| 3 |
| ZYDUS HEALTHCARE PHILIPPINES INC. | PHILIPPINES | $19.6K | 4 |
| AA MEDICAL PRODUCTS LTD. | MYANMAR | $7.0K | 1 |
| AA MEDICAL PRODUCTS LIMITED | MYANMAR | $2.5K | 1 |
Zydus Lifesciences Limited supplies Zinc to 9 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by HEMAS PHARMACEUTICALS (PVT) LTD (SRI LANKA) and HEMAS PHARMACEUTICAL (PVT) LTD. (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| FERUP SG 4X30 CAPSULES,(FERROUS FUMARATEB.P. 152MG,FOLIC ACID 400MCG, ZINCE,B NO.CYA1019,CYA1020,MFG.03/24,EXP.02/26 |
| $50.0K |
| 1 |
| ZINC SULFATE INJECTION USP 10 MG/10 ML 1MG/ML - 1 X 25S VIAL | $50.0K | 1 |
| ZINC SULFATE INJECTION USP 10MG/10ML 1 MG/ML [371 PACK X 1 X 25] | $50.0K | 1 |
Zydus Lifesciences Limited exports 23 distinct Zinc formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ZINC SULFATE INJECTION USP 10 MG/10ML 1MG/ML [1X25 VIAL PER with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
| $12.9K |
| 14 | KUSUM HEALTHCARE PRIVATE LIMITED | $1.1M | 65 | 8 | $16.9K |
Zydus Lifesciences Limited ranks #5 among 791 Indian Zinc exporters. Average shipment value of $50.0K compared to the market average of $44.3K. The closest competitors by value are DR REDDYS LABORATORIES LIMITED and MEPRO PHARMACEUTICALS PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 2,264+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Zinc. For current shipment-level data, contact TransData Nexus.